DE2167168C2 - Flüssiges, Leberverdauungsbrühe, -extrakt oder -infusion enthaltendes Nährmedium zum anaeroben Züchten von Fusiformis nodosus und Verfahren zum anaeroben Züchten von Fusiformis nodusus - Google Patents
Flüssiges, Leberverdauungsbrühe, -extrakt oder -infusion enthaltendes Nährmedium zum anaeroben Züchten von Fusiformis nodosus und Verfahren zum anaeroben Züchten von Fusiformis nodususInfo
- Publication number
- DE2167168C2 DE2167168C2 DE2167168A DE2167168A DE2167168C2 DE 2167168 C2 DE2167168 C2 DE 2167168C2 DE 2167168 A DE2167168 A DE 2167168A DE 2167168 A DE2167168 A DE 2167168A DE 2167168 C2 DE2167168 C2 DE 2167168C2
- Authority
- DE
- Germany
- Prior art keywords
- volume
- medium
- nodosus
- carbon dioxide
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007788 liquid Substances 0.000 title claims description 43
- 241000605721 Dichelobacter nodosus Species 0.000 title claims description 28
- 235000015097 nutrients Nutrition 0.000 title claims description 28
- 210000004185 liver Anatomy 0.000 title claims description 27
- 238000000034 method Methods 0.000 title claims description 27
- 239000000284 extract Substances 0.000 title claims description 7
- 230000001079 digestive effect Effects 0.000 title claims description 5
- 238000001802 infusion Methods 0.000 title claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 52
- 239000001569 carbon dioxide Substances 0.000 claims description 24
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 21
- 210000000496 pancreas Anatomy 0.000 claims description 18
- 239000007789 gas Substances 0.000 claims description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 241001494479 Pecora Species 0.000 claims description 14
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 8
- 235000018417 cysteine Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 108010009004 proteose-peptone Proteins 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 102000004142 Trypsin Human genes 0.000 claims description 6
- 108090000631 Trypsin Proteins 0.000 claims description 6
- 229910052786 argon Inorganic materials 0.000 claims description 6
- 239000001307 helium Substances 0.000 claims description 6
- 229910052734 helium Inorganic materials 0.000 claims description 6
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000012588 trypsin Substances 0.000 claims description 6
- 241000283690 Bos taurus Species 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- 229910002090 carbon oxide Inorganic materials 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 238000009395 breeding Methods 0.000 claims description 3
- 230000001488 breeding effect Effects 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 239000002609 medium Substances 0.000 description 56
- 229920001817 Agar Polymers 0.000 description 18
- 239000008272 agar Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 15
- 210000000078 claw Anatomy 0.000 description 14
- 229960005486 vaccine Drugs 0.000 description 13
- 239000012298 atmosphere Substances 0.000 description 7
- 229960002433 cysteine Drugs 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 241000605952 Fusobacterium necrophorum Species 0.000 description 4
- 235000010633 broth Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000010801 foot rot Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 210000000003 hoof Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000831652 Salinivibrio sharmensis Species 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101710174520 Claw keratin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101710151387 Serine protease 1 Proteins 0.000 description 1
- 102100032491 Serine protease 1 Human genes 0.000 description 1
- 101710119665 Trypsin-1 Proteins 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- HCIUVGKUNYOVBM-UHFFFAOYSA-N [hydroxy(phenylmercuriooxy)boranyl]oxy-phenylmercury Chemical group C=1C=CC=CC=1[Hg]OB(O)O[Hg]C1=CC=CC=C1 HCIUVGKUNYOVBM-UHFFFAOYSA-N 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/114—Fusobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/801—Anerobic cultivation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4026070A GB1375544A (oth) | 1970-08-20 | 1970-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2167168C2 true DE2167168C2 (de) | 1984-03-29 |
Family
ID=10414012
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2167168A Expired DE2167168C2 (de) | 1970-08-20 | 1971-08-20 | Flüssiges, Leberverdauungsbrühe, -extrakt oder -infusion enthaltendes Nährmedium zum anaeroben Züchten von Fusiformis nodosus und Verfahren zum anaeroben Züchten von Fusiformis nodusus |
| DE2141901A Expired DE2141901C3 (de) | 1970-08-20 | 1971-08-20 | Steriler Impfstoff, der abgetötete Organismen des genus Fusiformis nodosus enthält |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2141901A Expired DE2141901C3 (de) | 1970-08-20 | 1971-08-20 | Steriler Impfstoff, der abgetötete Organismen des genus Fusiformis nodosus enthält |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3843451A (oth) |
| JP (1) | JPS5545192B1 (oth) |
| AR (1) | AR195954A1 (oth) |
| AU (1) | AU451635B2 (oth) |
| BE (1) | BE771536A (oth) |
| DE (2) | DE2167168C2 (oth) |
| FR (1) | FR2103402B1 (oth) |
| IE (1) | IE35729B1 (oth) |
| IT (1) | IT1045527B (oth) |
| NL (1) | NL7111442A (oth) |
| NO (2) | NO141564C (oth) |
| ZA (1) | ZA715544B (oth) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU529322B2 (en) * | 1979-07-27 | 1983-06-02 | Pitman-Moore, Inc. | Antigenic compositions |
| NZ503636A (en) * | 1997-10-17 | 2002-05-31 | Fort Dodge Australia Pty | Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose |
| DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
-
1971
- 1971-08-16 US US00172309A patent/US3843451A/en not_active Expired - Lifetime
- 1971-08-19 BE BE771536A patent/BE771536A/xx not_active IP Right Cessation
- 1971-08-19 JP JP6330571A patent/JPS5545192B1/ja active Pending
- 1971-08-19 IE IE1051/71A patent/IE35729B1/xx unknown
- 1971-08-19 NL NL7111442A patent/NL7111442A/xx unknown
- 1971-08-19 FR FR7130222A patent/FR2103402B1/fr not_active Expired
- 1971-08-19 NO NO3094/71A patent/NO141564C/no unknown
- 1971-08-19 AU AU32522/71A patent/AU451635B2/en not_active Expired
- 1971-08-19 ZA ZA715544A patent/ZA715544B/xx unknown
- 1971-08-19 IT IT52380/71A patent/IT1045527B/it active
- 1971-08-20 DE DE2167168A patent/DE2167168C2/de not_active Expired
- 1971-08-20 DE DE2141901A patent/DE2141901C3/de not_active Expired
-
1972
- 1972-07-17 NO NO2548/72A patent/NO141565C/no unknown
-
1973
- 1973-01-01 AR AR19595473D patent/AR195954A1/es active
Non-Patent Citations (1)
| Title |
|---|
| NICHTS-ERMITTELT * |
Also Published As
| Publication number | Publication date |
|---|---|
| NO141564B (no) | 1979-12-27 |
| AU3252271A (en) | 1973-02-22 |
| DE2141901A1 (de) | 1972-02-24 |
| JPS5545192B1 (oth) | 1980-11-17 |
| NO141565B (no) | 1979-12-27 |
| IE35729B1 (en) | 1976-05-12 |
| NO141565C (no) | 1980-04-09 |
| IT1045527B (it) | 1980-05-10 |
| NL7111442A (oth) | 1972-02-22 |
| US3843451A (en) | 1974-10-22 |
| FR2103402B1 (oth) | 1975-06-06 |
| AU451635B2 (en) | 1974-08-15 |
| NO141564C (no) | 1980-04-09 |
| DE2141901B2 (de) | 1980-02-14 |
| DE2141901C3 (de) | 1980-10-09 |
| AR195954A1 (es) | 1973-11-23 |
| IE35729L (en) | 1972-02-20 |
| BE771536A (fr) | 1972-02-21 |
| FR2103402A1 (oth) | 1972-04-14 |
| ZA715544B (en) | 1973-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2954387C2 (de) | Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung | |
| DE69021761T2 (de) | Impfstoff gegen Tinea. | |
| DE3686158T2 (de) | Impfstoff gegen mastitis. | |
| DE2923144A1 (de) | Vakzin zur prophylaxe und behandlung von durch trichophyton mentagrophytes hervorgerufenen trichophytien und seine herstellung | |
| DE2167168C2 (de) | Flüssiges, Leberverdauungsbrühe, -extrakt oder -infusion enthaltendes Nährmedium zum anaeroben Züchten von Fusiformis nodosus und Verfahren zum anaeroben Züchten von Fusiformis nodusus | |
| DE2423129A1 (de) | Verfahren zur herstellung temperaturempfindlicher, nicht pathogener mutantenstaemme von rinder-adeno-virusstaemmen und diese virusstaemme enthaltende lebendvakzine | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE2843295C2 (oth) | ||
| DE2415353C2 (oth) | ||
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE60213785T2 (de) | Saponin inaktivierte mykoplasma impfstoffe | |
| DE1492255A1 (de) | Immunisierungszubereitung | |
| DE191752C (oth) | ||
| DE3028248A1 (de) | Emulgierte antigenzubereitung aus bacteroides nodosus und aluminiumadjuvans und ihre verwendung als impfstoff | |
| DE2134930A1 (de) | Antigene Extrakte | |
| DE2223864A1 (de) | Verbessertes Verfahren zur Erzeugung von Glucose-Isomerase | |
| DE2805029C2 (de) | Impfstoff gegen virale hämorrhagische Sepsis von Forellen sowie Verfahren zu dessen Herstellung | |
| DE1467849A1 (de) | Verfahren zur Herstellung von Vakzinen | |
| DE2121237C3 (de) | Verwendung einer Zellinie zur Züchtung von Viren | |
| DE1171559B (de) | Verfahren zur Herstellung von Impfstoffkonzentraten von Brucella abortus | |
| DE940315C (de) | Verfahren zur Herstellung von Lymphe gegen Schweinepest | |
| DE2158293B2 (de) | Lebende Herpes-Viren der Gruppe B enthaltende Vaccine und Verfahren zu ihrer Herstellung | |
| DE2600323A1 (de) | Verfahren zur herstellung eines produkts mit biologischer aktivitaet | |
| DE3136430A1 (de) | Orfvirus, verfahren zur herstellung eines orfvirus-lebendimpfstoffes und seine verwendung zur parenteralen schutzimpfung gegen die orf-infektionen der schafe und ziegen | |
| DE221266C (oth) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OI | Miscellaneous see part 1 | ||
| OI | Miscellaneous see part 1 | ||
| OI | Miscellaneous see part 1 | ||
| OD | Request for examination | ||
| AC | Divided out of |
Ref country code: DE Ref document number: 2141901 Format of ref document f/p: P |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |